DA
DCF Advisers Portfolio holdings
AUM
$208M
1-Year Return
21.52%
This Quarter Return
+6.14%
1 Year Return
+21.52%
3 Year Return
+75.42%
5 Year Return
+129.34%
10 Year Return
–
AUM
$197M
AUM Growth
+$9.74M
(+5.2%)
Cap. Flow
+$1.46M
Cap. Flow
% of AUM
0.74%
Top 10 Holdings %
Top 10 Hldgs %
48.07%
Holding
98
New
12
Increased
18
Reduced
28
Closed
7
Top Buys
| 1 |
General Motors
GM
|
$2.59M |
| 2 |
Verizon
VZ
|
$2.49M |
| 3 |
AbbVie
ABBV
|
$2.27M |
| 4 |
CVS Health
CVS
|
$1.62M |
| 5 |
Prothena Corp
PRTA
|
$1.15M |
Top Sells
| 1 |
SPDR Gold Trust
GLD
|
$2.96M |
| 2 |
Intel
INTC
|
$2.44M |
| 3 |
XLNX
Xilinx Inc
XLNX
|
$1.67M |
| 4 |
Gilead Sciences
GILD
|
$1.66M |
| 5 |
Teradata
TDC
|
$1.35M |
Sector Composition
| 1 | Healthcare | 41.17% |
| 2 | Technology | 17.46% |
| 3 | Communication Services | 11.33% |
| 4 | Financials | 6.23% |
| 5 | Consumer Discretionary | 5.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Apple
AAPL
$3.53T
| $733K | 0.32% |
6,000
-500
| -8% | -$61.1K |
|
52
NXP Semiconductors
NXPI
$56.3B
| $705K | 0.31% |
3,500
| – | – |
|
53
Nokia
NOK
$24.6B
| $669K | 0.29% |
169,000
-121,000
| -42% | -$479K |
|
54
Gen Digital
GEN
$18.2B
| $638K | 0.28% |
30,000
| – | – |
|
55
Nektar Therapeutics
NKTR
$620M
| $626K | 0.27% |
2,087
| – | – |
|
56
Kohl's
KSS
$1.77B
| $596K | 0.26% |
10,000
| – | – |
|
57
FibroGen
FGEN
$47.7M
| $594K | 0.26% |
685
-555
| -45% | -$481K |
|
58
Microsoft
MSFT
$3.77T
| $589K | 0.26% |
2,500
| – | – |
|
59
Virgin Galactic
SPCE
$176M
| $567K | 0.25% |
925
-825
| -47% | -$506K |
|
|
AYX
60
DELISTED
Alteryx, Inc.
AYX
| $550K | 0.24% |
6,625
+625
| +10% | +$51.9K |
|
61
Pfizer
PFE
$139B
| $543K | 0.24% |
+15,000
| New | +$543K |
|
62
NVIDIA
NVDA
$4.16T
| $534K | 0.23% |
+40,000
| New | +$534K |
|
63
Esperion Therapeutics
ESPR
$490M
| $485K | 0.21% |
17,286
-21,214
| -55% | -$595K |
|
|
QTNT
64
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $484K | 0.21% |
+3,288
| New | +$484K |
|
65
Ovid Therapeutics
OVID
$92.4M
| $438K | 0.19% |
+109,001
| New | +$438K |
|
66
Matinas BioPharma
MTNB
$9.5M
| $420K | 0.18% |
8,000
+1,894
| +31% | +$99.4K |
|
|
APTX
67
DELISTED
Aptinyx Inc. Common Stock
APTX
| $390K | 0.17% |
130,000
-1,000
| -0.8% | -$3K |
|
68
Vir Biotechnology
VIR
$722M
| $369K | 0.16% |
7,192
-13,808
| -66% | -$708K |
|
|
ARNA
69
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $347K | 0.15% |
5,000
-1,000
| -17% | -$69.4K |
|
70
Freeport-McMoran
FCX
$65.2B
| $329K | 0.14% |
10,000
-10,000
| -50% | -$329K |
|
71
Genmab
GMAB
$16.7B
| $328K | 0.14% |
10,000
| – | – |
|
|
TBHC
72
The Brand House Collective, Inc. Common Stock
TBHC
$33.7M
| $295K | 0.13% |
10,500
-250
| -2% | -$7.02K |
|
|
73
Teradata
TDC
$1.93B
| $289K | 0.13% |
7,500
-35,000
| -82% | -$1.35M |
|
74
Salesforce
CRM
$231B
| $265K | 0.12% |
1,250
+250
| +25% | +$53K |
|
75
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$304M
| $207K | 0.09% |
+9,500
| New | +$207K |
|